The president of the Portuguese Society of Pulmonology, António Morais, warned that patients should not underestimate symptoms and insisted on the importance of early diagnosis in fibrotic diseases, stressing that it is crucial to stop progression.
The campaign “When breathing is asphyxiating”, launched today, when World Pulmonary Fibrosis Awareness month is scheduled, involves the Respira Association, the Portuguese Lung Foundation and the Portuguese Pulmonology Society.
This initiative aims to alert to the importance of early diagnosis, warning that the progression of fibrosis is irreversible and that many cases are still diagnosed late, as “there are patients who take four, five years or more before getting an accurate diagnosis”.
Nuformix plc (LON:NFX) is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology using drug repurposing.
